Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients

Authors :: Jori, B.
Kamps, R.
Xanthoulea, S.
Delvoux, B.
Blok, M.J.
Vijver, K.K. van de
Koning, B. de
Oei, F.T.
Tops, C.M.
Speel, E.J.M.
Kruitwagen, R.F.
Gomez-Garcia, E.B.
Romano, A.
Source :: Oncotarget, 6(38), 41108-41122
Publication Year :: 2015

Subjects :: next generation sequencing
Lynch syndrome
endometrial cancer
genetic risk modifier
estrogens

Tools